These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11532642)

  • 1. Neurobehavioral aspects of movement disorders.
    Glosser G
    Neurol Clin; 2001 Aug; 19(3):535-51, v. PubMed ID: 11532642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
    Mayeux R
    Neurol Clin; 1984 Aug; 2(3):527-40. PubMed ID: 6085395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric comorbidities in Huntington's and Parkinson's Disease: A United States claims database analysis.
    Ishihara L; Oliveri D; Wild EJ
    Ann Clin Transl Neurol; 2021 Jan; 8(1):126-137. PubMed ID: 33217173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study.
    Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C
    Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia and cognitive changes in Huntington's disease.
    Morris M
    Adv Neurol; 1995; 65():187-200. PubMed ID: 7872140
    [No Abstract]   [Full Text] [Related]  

  • 6. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
    Pillon B; Dubois B; Agid Y
    Ann N Y Acad Sci; 1991; 640():224-7. PubMed ID: 1837977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Motor, cognitive and affective disorders in Parkinson's disease].
    Vendrova MI; Golubev VL; Sadekov RA; Veĭn AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(3):13-7. PubMed ID: 12830500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia.
    Ferrarese C; Appollonio I; Frigo M; Meregalli S; Piolti R; Tamma F; Frattola L
    Neurology; 1990 Apr; 40(4):632-5. PubMed ID: 2138718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatry of Huntington's disease.
    Rosenblatt A
    Dialogues Clin Neurosci; 2007; 9(2):191-7. PubMed ID: 17726917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
    Pillon B; Dubois B; Ploska A; Agid Y
    Neurology; 1991 May; 41(5):634-43. PubMed ID: 1827513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral symptoms associated with Huntington's disease.
    Anderson KE; Marshall FJ
    Adv Neurol; 2005; 96():197-208. PubMed ID: 16383221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuropsychiatry Of Movement Disorders].
    Orjuela-Rojas JM; Barrios Vincos GA; Martínez Gallego MA
    Rev Colomb Psiquiatr; 2017 Oct; 46 Suppl 1():59-68. PubMed ID: 29037340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological and social problems of Parkinson's disease.
    Ring H
    Br J Hosp Med; 1993 Jan 20-Feb 2; 49(2):111-6. PubMed ID: 8435671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood and emotional disorders associated with parkinsonism, Huntington disease, and other movement disorders.
    Bono AD; Twaite JT; Krch D; McCabe DL; Scorpio KA; Stafford RJ; Borod JC
    Handb Clin Neurol; 2021; 183():175-196. PubMed ID: 34389117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcortical dementia. Review of an emerging concept.
    Cummings JL; Benson DF
    Arch Neurol; 1984 Aug; 41(8):874-9. PubMed ID: 6235797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of psychosis in movement disorder patients.
    Chou KL; Borek LL; Friedman JH
    Expert Opin Pharmacother; 2007 May; 8(7):935-43. PubMed ID: 17472539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Self-awareness of deficits in Huntington's and Parkinson's disease].
    Sitek EJ; Sławek J; Wieczorek D
    Psychiatr Pol; 2008; 42(3):393-403. PubMed ID: 19899567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases.
    Claus JJ; Mohr E
    Acta Neurol Scand; 1996 May; 93(5):346-51. PubMed ID: 8800345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abstracts of the 5th International Congress on Mental Dysfunction in Parkinson's Disease, June 12-14, 2006, Amsterdam, The Netherlands.
    Parkinsonism Relat Disord; 2006 Jun; 12 Suppl 1():1-36. PubMed ID: 16858840
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive impairment in Parkinson's disease.
    Girotti F; Marano R; Grazzi L; Scigliano G; Caraceni T
    J Neural Transm Suppl; 1986; 22():163-70. PubMed ID: 3465870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.